Antithrombin supplementation attenuates heparin resistance in plasma spiked with Gla-domainless factor Xa S195A in vitro
British Journal of Anaesthesia · 2024
DOI: 10.1016/j.bja.2024.02.027 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Anaesthesia, 2024. Verfasst von Yuko Mishima und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA. Hauptthemen laut MEDLINE: Antithrombins, Drug Resistance, Factor Xa, Factor Xa Inhibitors. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Society of Cardiovascular Anesthesiologists, The University of Oklahoma Health Sciences Center.
Abstract (Originalsprache)
BACKGROUND: Andexanet alfa is a Gla-domainless mutant (S195A) factor Xa (GDXa) approved for acute reversal of oral factor Xa inhibitors. Cardiac surgery patients exposed to andexanet before cardiopulmonary bypass often exhibit severe heparin resistance. There is a paucity of data on the effectiveness and optimal dosage of antithrombin use in this setting. The objective of this study was to evaluate the in vitro effect of increased heparin with antithrombin levels on attenuating heparin resistance induced by GDXa. METHODS: Heparinised normal pooled plasma and cardiopulmonary bypass plasma were spiked with GDXa 4 μM. Tissue factor-activated thrombin generation was used to assess heparin reversal effects of GDXa and restoration of anticoagulation with additional heparin with and without antithrombin. Serum thrombin-antithrombin complex, antithrombin activity, and tissue factor pathway inhibitor were also measured in tissue factor-activated, recalcified cardiopulmonary bypass plasma spiked with GDXa. RESULTS: In normal pooled plasma, GDXa-induced heparin reversal was mitigated by maintaining a high heparin concentration (12 U ml-1) and supplementing antithrombin (1.5-4.5 μM) based on peak and velocity of thrombin generation. Heparin reversal by GDXa was also demonstrated in cardiopulmonary bypass plasma, but supplementing both heparin (8 U ml-1) and antithrombin (3 μM) attenuated GDXa-induced changes in peak and velocity of thrombin generation by 72.5% and 72.2%, respectively. High heparin and antithrombin levels attenuated thrombin-antithrombin complex formation in tissue factor-activated, GDXa-spiked cardiopulmonary bypass plasma by 85.7%, but tissue factor pathway inhibitor remained depleted compared with control cardiopulmonary bypass plasma. CONCLUSIONS: Simultaneous supplementation of heparin and antithrombin mitigate GDXa-induced heparin resistance by compensating for the loss of tissue factor pathway inhibitor.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
- Duke University Medical Center, Department of Anesthesiology, Critical Care, and Surgery (Cardiothoracic), Durham, NC, USA.
- Department of Anesthesiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA; Department of Surgery, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
- Department of Anesthesiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA. Electronic address: kenichi-tanaka@ouhsc.edu.
Förderung
- Society of Cardiovascular Anesthesiologists
- The University of Oklahoma Health Sciences Center
Zitieren
APA
Mishima, Y., Butt, A. L., Vandyck, K. B., Levy, J. H., Stewart, K. E., & Tanaka, K. A. (2024). Antithrombin supplementation attenuates heparin resistance in plasma spiked with Gla-domainless factor Xa S195A in vitro. British Journal of Anaesthesia. https://doi.org/10.1016/j.bja.2024.02.027
Vancouver
Mishima Y, Butt AL, Vandyck KB, Levy JH, Stewart KE, Tanaka KA. Antithrombin supplementation attenuates heparin resistance in plasma spiked with Gla-domainless factor Xa S195A in vitro. British Journal of Anaesthesia. 2024. doi:10.1016/j.bja.2024.02.027
BibTeX
@article{Mishima2024,
author = {Mishima, Yuko and Butt, Amir L and Vandyck, Kofi B and Levy, Jerrold H and Stewart, Kenneth E and Tanaka, Kenichi A},
title = {Antithrombin supplementation attenuates heparin resistance in plasma spiked with Gla-domainless factor Xa S195A in vitro},
journal = {British Journal of Anaesthesia},
year = {2024},
doi = {10.1016/j.bja.2024.02.027}
}
EUVIMED